Stacey Schott is a Cardiology physician affiliated with Johns Hopkins University. OpenAlex indexes 20 publications with 814 citations (h-index 9); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
301 Mason F Lord Drive
Cardiology 301 Bldg, Suite 2400
Baltimore, MD 21224
Telephone
410-550-0845Provider last certified this registry record 30 Mar 2023.
Clinical trials
- Impact of the Corrie Lipids Digital Health Program on Lipid Optimization
Sponsor: Johns Hopkins University
- HEARt Sounds: Audio Recordings to Improve Discharge Communication for Cardiology Inpatients
Sponsor: Dartmouth-Hitchcock Medical Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
89.6%Statin24.2%Atorvastatin Calcium58%Rosuvastatin Calcium42%Part D≥45 patientsBeta blocker17%Metoprolol Succinate80%Carvedilol20%Part D≥34 patients+ 10 more classes in this area
Metabolism & gastrointestinal
5.3%SGLT2 inhibitor4.3%Jardiance100%Part D<11 patientsProton pump inhibitor1%Pantoprazole Sodium100%Part D<11 patientsBlood & clotting
5%Factor Xa inhibitor5%Eliquis100%Part D≥15 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Personalizing prevention for healthy cardiovascular aging: Geriatric cardiology in the 2024-2025 hypertension and dyslipidemia guidelines
American Journal of Preventive Cardiology
2026 - 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults
Journal of the American College of Cardiology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Roger Blumenthal, MD
Johns Hopkins University
Erin Michos, MD
Johns Hopkins University
Morgan Grams, MD
Johns Hopkins University
Mario Eisenberger, MD
Johns Hopkins University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”